Assenagon Asset Management S.A. Raises Stock Holdings in Option Care Health, Inc. $OPCH

Key Points

• Assenagon Asset Management S.A. increased its stake in Option Care Health, Inc. by 227.1% during the second quarter, owning approximately 635,758 shares valued at $20.6 million.
• Company insiders have also shown confidence in the stock, with Harry M. Jansen Kraemer, Jr. and Timothy P. Sullivan purchasing a total of 56,000 shares in August, reflecting a significant increase in their ownership.
• Analysts have a consensus price target of $35.75 for Option Care Health, with eight analysts recommending a Buy rating, indicating strong market confidence in the company's future performance.

Assenagon Asset Management S.A. grew its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 227.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 635,758 shares of the company's stock after buying an additional 441,417 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.39% of Option Care Health worth $20,649,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Northwestern Mutual Wealth Management Co. increased its holdings in Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares in the last quarter. Brooklyn Investment Group increased its holdings in Option Care Health by 186.6% in the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after acquiring an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio increased its stake in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after purchasing an additional 332 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after purchasing an additional 599 shares in the last quarter. Finally, Wealthquest Corp purchased a new stake in shares of Option Care Health in the first quarter worth $66,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the company's stock in a transaction that occurred on Wednesday, August 20th. The stock was purchased at an average cost of $27.15 per share, with a total value of $977,400.00. Following the purchase, the director owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy P. Sullivan bought 20,000 shares of the company's stock in a transaction on Thursday, August 21st. The shares were acquired at an average price of $27.51 per share, with a total value of $550,200.00. Following the transaction, the director directly owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 59,411 shares of company stock valued at $1,627,576. Company insiders own 0.64% of the company's stock.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $28.67 on Tuesday. The stock has a market cap of $4.65 billion, a price-to-earnings ratio of 22.94, a price-to-earnings-growth ratio of 1.72 and a beta of 0.83. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The stock has a 50 day moving average price of $28.79 and a 200-day moving average price of $31.17. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. Option Care Health's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. JMP Securities increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Barrington Research reiterated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. Finally, Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.